FI109360B - Ihmisen follikkelia stimuloivan hormonin reseptori - Google Patents

Ihmisen follikkelia stimuloivan hormonin reseptori Download PDF

Info

Publication number
FI109360B
FI109360B FI934023A FI934023A FI109360B FI 109360 B FI109360 B FI 109360B FI 934023 A FI934023 A FI 934023A FI 934023 A FI934023 A FI 934023A FI 109360 B FI109360 B FI 109360B
Authority
FI
Finland
Prior art keywords
fsh
receptor
leu
ser
fragment
Prior art date
Application number
FI934023A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI934023A (fi
FI934023A0 (fi
Inventor
Christie Ann Kelton
Shirley Vui Yen Cheng
Noreen Patrice Nugent
Rene Lynn Schweickhardt
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24688922&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI109360(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of FI934023A publication Critical patent/FI934023A/fi
Publication of FI934023A0 publication Critical patent/FI934023A0/fi
Application granted granted Critical
Publication of FI109360B publication Critical patent/FI109360B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
FI934023A 1991-03-15 1993-09-14 Ihmisen follikkelia stimuloivan hormonin reseptori FI109360B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US67008591A 1991-03-15 1991-03-15
US67008591 1991-03-15
PCT/US1992/000122 WO1992016620A1 (en) 1991-03-15 1992-01-02 Human follicle stimulating hormone receptor
US9200122 1992-01-02

Publications (3)

Publication Number Publication Date
FI934023A FI934023A (fi) 1993-09-14
FI934023A0 FI934023A0 (fi) 1993-09-14
FI109360B true FI109360B (fi) 2002-07-15

Family

ID=24688922

Family Applications (1)

Application Number Title Priority Date Filing Date
FI934023A FI109360B (fi) 1991-03-15 1993-09-14 Ihmisen follikkelia stimuloivan hormonin reseptori

Country Status (19)

Country Link
US (3) US5744448A (de)
EP (2) EP1167385B1 (de)
JP (1) JP3581148B2 (de)
KR (1) KR100245250B1 (de)
AT (2) ATE224446T1 (de)
AU (1) AU671417B2 (de)
CA (1) CA2106061C (de)
DE (2) DE69233805D1 (de)
DK (1) DK0575357T3 (de)
ES (1) ES2183806T3 (de)
FI (1) FI109360B (de)
GE (1) GEP19991604B (de)
LT (1) LT3973B (de)
LV (1) LV10724B (de)
MX (1) MX9203350A (de)
NO (1) NO315517B1 (de)
RU (1) RU2193599C2 (de)
UA (1) UA43826C2 (de)
WO (1) WO1992016620A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993020199A1 (en) * 1992-03-30 1993-10-14 Akzo Nobel N.V. Human gonadotropin receptor (fsh receptor)
SI0894141T1 (en) 1996-02-20 2005-10-31 Applied Research Systems Ars Holding N.V. Hybrid proteins which form heterodimers
CA2250975A1 (en) * 1996-04-15 1997-10-23 The Board Of Trustees Of The Leland Stanford Junior University Soluble 7-transmembrane domain g-protein-coupled receptor compositions and methods
US6521641B1 (en) 1998-10-08 2003-02-18 Allergan, Inc. Male anti-fertility agents
WO2000073416A1 (en) * 1999-05-28 2000-12-07 University Of Cincinnati Antisense oligonucleotides for fertility and menstrual cycle regulation and for chemopreventive and chemotherapeutic use
EP1287135A2 (de) * 2000-05-18 2003-03-05 Bayer Aktiengesellschaft Regulation eines menschlichen, follikel-stimulierenden hormon-ähnlichen g-protein gekoppelten rezeptors
US20030175889A1 (en) * 2002-01-23 2003-09-18 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated versions of human G protein coupled receptor: FSHR
EP1466620A1 (de) * 2003-04-11 2004-10-13 AXXAM S.r.l. Modulatoren des Follikel-stimulierenden Hormon-Rezeptors und ihre therapeutische Verwendung
US20100061976A1 (en) * 2008-07-24 2010-03-11 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Method for treating or preventing osteoporosis by reducing follicle stimulating hormone to cyclic physiological levels in a mammalian subject

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4652450A (en) * 1984-08-31 1987-03-24 Research Corporation Bacterial FSH binding inhibitor
US4761371A (en) 1985-02-12 1988-08-02 Genentech, Inc. Insulin receptor
US4859609A (en) * 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
US4921808A (en) * 1986-06-25 1990-05-01 The Albany Medical College Of Union University Method for determining follicle stimulating hormone
US4960700A (en) * 1986-12-24 1990-10-02 Genentech, Inc. Compositions and methods for the synthesis and assay of a mammalian enkephalinase
JPH04505103A (ja) * 1989-05-05 1992-09-10 ジェネンテク，インコーポレイテッド 糖タンパク質ホルモン受容体分子
US5155218A (en) * 1990-05-08 1992-10-13 Neurogenetic Corporation Dna encoding human 5-ht1d receptors

Also Published As

Publication number Publication date
AU1251492A (en) 1992-10-21
DE69232779D1 (de) 2002-10-24
ATE224446T1 (de) 2002-10-15
FI934023A (fi) 1993-09-14
UA43826C2 (uk) 2002-01-15
MX9203350A (es) 1992-08-01
ES2183806T3 (es) 2003-04-01
US5744448A (en) 1998-04-28
JPH06505157A (ja) 1994-06-16
DE69233805D1 (de) 2011-05-26
DE69232779T2 (de) 2003-01-30
LT3973B (en) 1996-05-27
WO1992016620A1 (en) 1992-10-01
CA2106061A1 (en) 1992-09-16
AU671417B2 (en) 1996-08-29
LTIP1631A (en) 1995-07-25
EP0575357A1 (de) 1993-12-29
LV10724B (en) 1995-12-20
JP3581148B2 (ja) 2004-10-27
NO315517B1 (no) 2003-09-15
EP1167385A3 (de) 2003-04-16
RU2193599C2 (ru) 2002-11-27
KR100245250B1 (en) 2000-02-15
FI934023A0 (fi) 1993-09-14
NO933272L (no) 1993-09-14
ATE505486T1 (de) 2011-04-15
LV10724A (lv) 1995-06-20
US6372711B1 (en) 2002-04-16
EP1167385B1 (de) 2011-04-13
NO933272D0 (no) 1993-09-14
GEP19991604B (en) 1999-04-29
CA2106061C (en) 2008-10-07
DK0575357T3 (da) 2002-11-25
EP0575357B1 (de) 2002-09-18
US6121016A (en) 2000-09-19
EP1167385A2 (de) 2002-01-02

Similar Documents

Publication Publication Date Title
EP0723555B1 (de) Chimäre proteine zur vermeidung der komplementaktivierung
AU616672B2 (en) Growth hormone receptor
US5658876A (en) Activin antagonists as novel contraceptives
US6261800B1 (en) Luteinizing hormone/choriogonadotropin (LH/CG) receptor
IE61563B1 (en) Interleukin-1 receptors
EP0658200B1 (de) Glucagonrezeptoren
JP2000507456A (ja) 拮抗的特性を有する血管内皮細胞増殖因子の変異体
JP2002514079A (ja) キメラｏｐｇポリペプチド
EP0579739A1 (de) Interleukin-8-rezeptoren, damit in zusammenhang stehende moleküle und verfahrensweisen
FI109360B (fi) Ihmisen follikkelia stimuloivan hormonin reseptori
EP0471030B1 (de) Glykoprotein-hormonrezeptor-moleküle
US20070179094A1 (en) Modulation of MDL-1 activity for treatment of inflammatory disease
US20040110218A1 (en) BMOG, a novel protein member of the myelin-oligodendrocyte glycoprotein family and its use for immunomodulatory purposes
AU625534B2 (en) Interleukin-1 receptors
US20050042205A1 (en) Glycoprotein hormone receptor molecules
TW509696B (en) Glial cell line-derived neurotrophic factor receptor
US20030139589A1 (en) G protein coupled receptor A4
WO1994019485A1 (en) A method for detecting compounds with growth hormone and growth hormone receptor activity
WO1988009818A1 (en) Growth hormone receptor

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: LABORATOIRES SERONO SA

Free format text: LABORATOIRES SERONO SA

PC Transfer of assignment of patent

Owner name: MERCK SERONO SA

Free format text: MERCK SERONO SA